|
1
|
Boehm A, Wichmann G, Mozet C and Dietz A:
Current therapy options in recurrent head and neck cancer. HNO.
58:762–769. 2010.(In German).
|
|
2
|
Ho AS, Kraus DH, Ganly I, Lee NY, Shah JP
and Morris LG: Decision making in the management of recurrent head
and neck cancer. Head Neck. Mar;2013.(Epub ahead of print).
|
|
3
|
Soltanian S and Matin MM: Cancer stem
cells and cancer therapy. Tumour Biol. 32:425–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Prince ME, Sivanandan R, Kaczorowski A, et
al: Identification of a subpopulation of cells with cancer stem
cell properties in head and neck squamous cell carcinoma. Proc Natl
Acad Sci USA. 104:973–978. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang P, Zuo H, Ozaki T, Nakagomi N and
Kakudo K: Cancer stem cell hypothesis in thyroid cancer. Pathol
Int. 56:485–489. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Allegra E and Trapasso S: Cancer stem
cells in head and neck cancer. Onco Targets Ther. 5:375–383. 2012.
View Article : Google Scholar
|
|
7
|
Hattermann K and Mentlein R: An infernal
trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in
tumor biology. Ann Anat. 195:103–110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suárez-Álvarez B, López-Vázquez A and
López-Larrea C: Mobilization and homing of hematopoietic stem
cells. Adv Exp Med Biol. 741:152–170. 2012.
|
|
9
|
Dar A, Goichberg P, Shinder V, et al:
Chemokine receptor CXCR4-dependent internalization and resecretion
of functional chemokine SDF-1 by bone marrow endothelial and
stromal cells. Nat Immunol. 6:1038–1046. 2005. View Article : Google Scholar
|
|
10
|
Faber A, Roderburg C, Wein F, et al: The
many facets of SDF-1alpha, CXCR4 agonists and antagonists on
hematopoietic progenitor cells. J Biomed Biotechnol.
2007:260652007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hale MD, Hayden JD and Grabsch HI:
Tumour-microenvironment interactions: role of tumour stroma and
proteins produced by cancer-associated fibroblasts in chemotherapy
response. Cell Oncol (Dordr). 36:95–112. 2013. View Article : Google Scholar
|
|
12
|
De La Luz Sierra M, Yang F, Narazaki M, et
al: Differential processing of stromal-derived factor-1alpha and
stromal-derived factor-1beta explains functional diversity. Blood.
103:2452–2459. 2004.
|
|
13
|
Shirozu M, Nakano T, Inazawa J, et al:
Structure and chromosomal localization of the human stromal
cell-derived factor 1 (SDF1) gene. Genomics. 28:495–500. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faber A, Hoermann K, Stern-Straeter J,
Schultz DJ and Goessler UR: Functional effects of SDF-1α on a
CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for
interactions in the cancer stem cell niche. Oncol Rep. 29:579–584.
2013.
|
|
15
|
Chute JP: Stem cell homing. Curr Opin
Hematol. 13:399–406. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Petit I, Goichberg P, Spiegel A, et al:
Atypical PKC-zeta regulates SDF-1-mediated migration and
development of human CD34+ progenitor cells. J Clin Invest.
115:168–176. 2005.PubMed/NCBI
|
|
17
|
Grenman R, Burk D, Virolainen E, Wagner
JG, Lichter AS and Carey TE: Radiosensitivity of head and neck
cancer cells in vitro. A 96-well plate clonogenic cell assay for
squamous cell carcinoma. Arch Otolaryngol Head Neck Surg.
114:427–431. 1988. View Article : Google Scholar
|
|
18
|
Spandidos DA: A unified theory for the
development of cancer. Biosci Rep. 6:691–708. 1986. View Article : Google Scholar
|
|
19
|
Podberezin M, Wen J and Chang CC: Cancer
stem cells: A review of potential clinical applications. Arch
Pathol Lab Med. Nov;2012.(Epub ahead of print).
|
|
20
|
La Porta CA: Thoughts about cancer stem
cells in solid tumors. World J Stem Cells. 4:17–20. 2012.PubMed/NCBI
|
|
21
|
Grosse-Gehling P, Fargeas CA, Dittfeld C,
et al: CD133 as a biomarker for putative cancer stem cells in solid
tumours: limitations, problems and challenges. J Pathol.
229:355–378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clay MR, Tabor M, Owen JH, et al:
Single-marker identification of head and neck squamous cell
carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck.
32:1195–1201. 2010. View Article : Google Scholar
|
|
23
|
Faber A, Goessler UR, Hoermann K, et al:
SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of
head and neck squamous cell carcinoma. Oncol Rep. 29:2325–2331.
2013.PubMed/NCBI
|
|
24
|
Sterz CM, Kulle C, Dakic B, et al: A
basal-cell-like compartment in head and neck squamous cell
carcinomas represents the invasive front of the tumor and is
expressing MMP-9. Oral Oncol. 46:116–122. 2010. View Article : Google Scholar
|
|
25
|
Nakajima M, Gohji K, Fabra A, Fidler IA
and Tsuruo T: Regulation of tumor metastasis and extracellular
matrix degradative enzyme production by microenvironments. Gan To
Kagaku Ryoho. 20:380–386. 1993.(In Japanese).
|
|
26
|
Faber A, Sauter A, Hoedt S, et al:
Alteration of MMP-2 and −14 expression by imatinib in HPV-positive
and -negative squamous cell carcinoma. Oncol Rep. 28:172–178.
2012.
|
|
27
|
Schultz JD, Rotunno S, Erben P, et al:
Down-regulation of MMP-2 expression due to inhibition of receptor
tyrosine kinases by imatinib and carboplatin in HNSCC. Oncol Rep.
25:1145–1151. 2011.
|
|
28
|
Teicher BA and Fricker SP: CXCL12
(SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Metzen E, Jin F, Brockmeier U and
Otterbach F: New insight into the SDF-1/CXCR4 axis in a breast
carcinoma model: hypoxia-induced endothelial SDF-1 and tumor cell
CXCR4 are required for tumor cell intravasation. Mol Cancer Res.
10:1021–1031. 2012. View Article : Google Scholar
|
|
30
|
Purizaca J, Meza I and Pelayo R: Early
lymphoid development and microenvironmental cues in B-cell acute
lymphoblastic leukemia. Arch Med Res. 43:89–101. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Juarez J, Dela Pena A, Baraz R, et al:
CXCR4 antagonists mobilize childhood acute lymphoblastic leukemia
cells into the peripheral blood and inhibit engraftment. Leukemia.
21:1249–1257. 2007. View Article : Google Scholar
|
|
32
|
Clatot F, Picquenot JM, Choussy O, et al:
Intratumoural level of SDF-1 correlates with survival in head and
neck squamous cell carcinoma. Oral Oncol. 47:1062–1068. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Geutskens SB, Andrews WD, van Stalborch
AM, et al: Control of human hematopoietic stem/progenitor cell
migration by the extracellular matrix protein Slit3. Lab Invest.
92:1129–1139. 2012. View Article : Google Scholar
|
|
34
|
Ghosh MC, Makena PS, Gorantla V, Sinclair
SE and Waters CM: CXCR4 regulates migration of lung alveolar
epithelial cells through activation of Rac1 and matrix
metalloproteinase-2. Am J Physiol Lung Cell Mol Physiol.
302:L846–L856. 2012. View Article : Google Scholar : PubMed/NCBI
|
